PRESS RELEASE published on 02/01/2024 at 14:10, 1 year 10 months ago CORRECTION BY SOURCE: Corporate Update on Clinical Evaluation of MedMira's Products MedMira Inc. provides an update on its submission to Health Canada, extending its intended use to address the increasing need in maternity screening. The company's syphilis component demonstrates promising results, with plans to submit a comprehensive dataset for additional claims approval by February 2024 MedMira Inc. Maternity Screening Health Canada Syphilis Comprehensive Dataset
PRESS RELEASE published on 02/01/2024 at 13:35, 1 year 10 months ago Corporate Update on Clinical Evaluation of MedMira’s Products MedMira Inc. provides update on Health Canada review process for maternity screening, highlighting increasing need due to rising syphilis infection rates. Company's syphilis test performance shows promising results for infectious case detection and maternity screening MedMira Inc. Health Canada Review Maternity Screening Syphilis Infection Rates Test Performance
PRESS RELEASE published on 12/30/2023 at 05:00, 1 year 11 months ago MedMira Reports First Quarter Results FY2024 MedMira Inc. (TSXV:MIR) has reported its financial results for the quarter ended October 31, 2023. The company achieved significant milestones during this period, including receiving US FDA 510(k) clearance for the HIV-2 claim on its Reveal® G4 Rapid HIV 1/2 antibody test. This approval positions MedMira as a key player in the HIV testing market and allows the company to expand its market share and revenue in the United States.
PRESS RELEASE published on 12/14/2023 at 04:30, 2 years ago U.S. FDA Approves MedMira's Advanced Reveal G4 Rapid HIV-1/2 Antibody Test
PRESS RELEASE published on 11/29/2023 at 05:00, 2 years ago MedMira Reports FY2023 Fourth Quarter and Year End Financial Results
PRESS RELEASE published on 09/28/2023 at 04:00, 2 years 2 months ago Update on MedMira’s Regulatory Path in Canada and the USA
PRESS RELEASE published on 06/30/2023 at 04:00, 2 years 5 months ago MedMira Reports Third Quarter Results FY2023
PRESS RELEASE published on 04/04/2023 at 03:00, 2 years 8 months ago MedMira Reports Second Quarter Results FY2023
PRESS RELEASE published on 03/14/2023 at 21:31, 2 years 9 months ago Update on MedMira’s Reveal TP (Syphilis) Clinical Trials in Canada
Published on 12/22/2025 at 15:00, 4 hours 52 minutes ago World Renowned Law Firm Grant & Eisenhofer Files Class Action Lawsuit Against Canadian Banks CIBC and RBC Alleging Illegal Stock Market Manipulation of Quantum BioPharma Shares
Published on 12/22/2025 at 14:40, 5 hours 12 minutes ago Namibia Critical Metals Inc. Receives Proceeds of $1,154,762 from Exercise of Warrants
Published on 12/22/2025 at 14:30, 5 hours 22 minutes ago Prospect Ridge Updates Diamond Drill Program at 100% Owned Camelot Copper-Gold Project in B.C.'S Cariboo Mining District
Published on 12/22/2025 at 14:00, 5 hours 52 minutes ago Rio Grande Resources Completes 2025 Field Program and Advances Drill Targeting at the Winston Gold-Silver Project
Published on 12/22/2025 at 14:00, 5 hours 52 minutes ago PPX Mining Appoints Ernest Mast as President and CEO and Announces Stock Option Grants
Published on 12/22/2025 at 19:31, 21 minutes ago EQS-Adhoc: Marley Spoon Group SE: CEO Daniel Raab Re-appointed and Contract to be Extended until June 2029
Published on 12/22/2025 at 19:00, 52 minutes ago PATRIMOINE ET COMMERCE: Déclarations des transactions sur actions propres (hors contrat de liquidité) réalisées le 19 décembre 2025
Published on 12/22/2025 at 18:20, 1 hour 31 minutes ago CGTN: How China drives high-quality development through technological innovation
Published on 12/22/2025 at 18:14, 1 hour 37 minutes ago Alzchem Group AG paves the way for continuity and further growth: Management Board contracts of Andreas Niedermaier and Andreas Lösler extended ahead of schedule
Published on 12/22/2025 at 18:33, 1 hour 19 minutes ago ABEO SE RENFORCE ET OBTIENT UNE TRÈS LARGE MAJORITÉ DU CAPITAL DE VOGO AVEC 90,84% DÉTENUS À L’ISSUE DE L’OFFRE RÉOUVERTE
Published on 12/22/2025 at 18:05, 1 hour 47 minutes ago Covivio - Treasury shares transactions between December 15th , 2025 and December 19th, 2025
Published on 12/22/2025 at 18:05, 1 hour 47 minutes ago Covivio - Déclaration des transactions sur actions propres réalisées du 15 décembre au 19 décembre 2025
Published on 12/22/2025 at 17:45, 2 hours 7 minutes ago Déclaration des transactions sur actions propres réalisées du 15 au 19 décembre 2025 dans le cadre du programme de rachat d’actions
Published on 12/22/2025 at 17:35, 2 hours 17 minutes ago DECLARATION HEBDOMADAIRE D'OPERATIONS EFFECTUEES DU 15 AU 19 DECEMBRE 2025